Barclays Initiates Coverage On HCA Healthcare with Overweight Rating, Announces Price Target of $356
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok has initiated coverage on HCA Healthcare (NYSE:HCA) with an Overweight rating and set a price target of $356.
March 06, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has initiated coverage on HCA Healthcare with an Overweight rating and a price target of $356.
The initiation of coverage by Barclays with an Overweight rating and a high price target suggests a positive outlook on HCA Healthcare's stock. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100